A pragmatic approach to Botulinum Toxin safety
Botulinum Toxin (BoNT) is widely used to treat hypertonia in pediatric patients. Although serious adverse events (AEs) occur infrequently, they can lead to significant patient morbidity and mortality. This paper will discuss potential safety risks that may affect outcomes, medical comorbidities, med...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publishing
2020-06-01
|
| Series: | Journal of Pediatric Rehabilitation Medicine |
| Acceso en liña: | https://doi.org/10.3233/PRM-200716 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|